pCR rates by intrinsic tumor subtypes
breast cancer
BREAST CANCER
PAM50 results were available for 77.4% (171/221) of patients in the TCH + P arm and 82.1% (183/223) in the T-DM1 + P arm (Table Consistent with the results from the intent-to-treat (ITT) population [pCR by PAM50 breast cancer subtype and hormone receptor status. 